Author: Asieris

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

August 28, 2026
Global Experts Convene at IFCPC 2026: Topical Photodynamic Therapy Reshapes the Individualized Management Paradigm for Cervical Precancerous Lesions

July 17, 2026

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma